Catalyst Wire Dossier Catalyst Wire Dossier

Edarbi (azilsartan medoxomil)

Azilsartan medoxomil · Takeda Pharmaceuticals U.S.A., Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Edarbi (azilsartan medoxomil), covering 2013-12-13 to 2013-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease [Phase 3]

See pricing